Louis Sullivan, Director at Henry Schein, holds 13.06K shares in United Therapeutics (Ticker: UTHR), holds 87.27K shares in Emergent Biosolutions (Ticker: EBS), holds 34.93K shares in Henry Schein (Ticker: HSIC). Most recently, Louis Sullivan Sold ― shares of United Therapeutics on May 06, 2024 for an estimated value of 1.33M.